Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer

Recently proposed events associated with the progression of cervical intraepithelial neoplasia (CIN) 2/3 to cervical carcinoma include integration of human papillomavirus (HPV) into the host genome, genomic instability, and an increase in chromosome 3q copy number. In particular, the gene coding for the RNA component of telomerase (TERC) at 3q26 has been implicated as a possible candidate gene. Since it is not known to date how these events are temporally related during cervical carcinogenesis, the aim of the present study was to assess the correlation between TERC gene copy number and the physical status of HPV during progression in cervical neoplasia. Solitary precursor lesions of the uterine cervix (CIN 2/3, n = 17), lesions associated with a micro‐invasive carcinoma (CIN 3&mCA, n = 13), and advanced invasive carcinomas (invCA, n = 7) were analysed by fluorescence in situ hybridization (FISH) to determine the physical status of the virus and TERC gene copy number. The TERC gene was increasingly gained with progression of CIN 2/3 (3 of 17) through CIN 3&mCA (7 of 13) to invCA (5 of 7). In the lesions exhibiting gain of TERC, the virus was predominantly integrated. This was seen in eight of ten diploid lesions, indicating that these events can occur prior to aneuploidization and are strongly associated with the progression of CIN 3 to mCA and invCA (p < 0.001). With progression to carcinoma, a number of these lesions show polyploidization, resulting in aneuploidy and high TERC gene copy numbers. In conclusion, genomic integration of oncogenic HPV and gain of the human telomerase gene TERC appear to be important associated genetic events in the progression of uterine cervical dysplasia to invasive cancer. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  P Komminoth,et al.  Amplification Methods to Increase the Sensitivity of In Situ Hybridization: Play CARD(S) , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  H. Hollema,et al.  Telomerase in (pre)neoplastic cervical disease. , 2000, Human pathology.

[3]  M. von Knebel Doeberitz.  New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. , 2002, European journal of cancer.

[4]  The pathology of cervical neoplasia. , 1996, Current opinion in obstetrics & gynecology.

[5]  Kerstin Heselmeyer-Haddad,et al.  Tumorigenesis and Neoplastic Progression Genomic Amplification of the Human Telomerase Gene ( TERC ) in Pap Smears Predicts the Development of Cervical Cancer , 2005 .

[6]  M. J. van de Vijver,et al.  Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix , 1999, Genes, chromosomes & cancer.

[7]  E. Franco,et al.  Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.

[8]  Magnus von Knebel Doeberitz,et al.  DNA Aneuploidy and Integration of Human Papillomavirus Type 16 E6/E7 Oncogenes in Intraepithelial Neoplasia and Invasive Squamous Cell Carcinoma of the Cervix Uteri , 2004, Clinical Cancer Research.

[9]  L. Chow,et al.  Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. , 2001, Cancer research.

[10]  Chen-Yang Shen,et al.  PIK3CA as an oncogene in cervical cancer , 2000, Oncogene.

[11]  J. Nowak.  Telomerase, cervical cancer, and human papillomavirus. , 2000, Clinics in laboratory medicine.

[12]  F. Smedts,et al.  HPV in situ hybridization: Impact of different protocols on the detection of integrated HPV , 2005, International journal of cancer.

[13]  J. Jen,et al.  AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Robben,et al.  Interphase cytogenetic analysis of cervical intraepithelial neoplasia. , 1998, The American journal of pathology.

[15]  W. Dinjens,et al.  A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8 , 2003, International journal of cancer.

[16]  E. Speel,et al.  Tyramide signal amplification for DNA and mRNA in situ hybridization. , 2006, Methods in molecular biology.

[17]  C. Lundsteen,et al.  Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. , 2001, Cancer genetics and cytogenetics.

[18]  V. Golubovskaya,et al.  Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein , 1998, Oncogene.

[19]  F. Ramaekers,et al.  Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  M. von Knebel Doeberitz,et al.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. , 1999, Cancer research.

[21]  K. Cooper,et al.  Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. , 1991, Journal of clinical pathology.

[22]  F. Jänicke,et al.  Relationship Between Telomerase Activation and HPV 16/18 Oncogene Expression in Squamous Intraepithelial Lesions and Squamous Cell Carcinomas of the Uterine Cervix , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  A. Hanselaar,et al.  Numerical aberrations of chromosome 1 in cervical intraepithelial neoplasia are strongly associated with infection with high‐risk human papillomavirus types , 2002, The Journal of pathology.

[24]  K. Cooper,et al.  Human papillomavirus integration: detection by in situ hybridization and potential clinical application , 2004, The Journal of pathology.

[25]  K. Méhes,et al.  Clinical manifestations of genetic instability overlap one another , 2008, Pathology & Oncology Research.

[26]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[27]  K. Shroyer,et al.  Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma , 2002, Oncogene.

[28]  E. Speel,et al.  Rapid Synthesis of Biotin-, Digoxigenin-, Trinitrophenyl-, and Fluorochrome-labeled Tyramides and Their Application for In Situ Hybridization Using CARD Amplification , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[30]  E. Schröck,et al.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Jen,et al.  Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma , 2000, International journal of cancer.

[32]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[33]  David I. Smith,et al.  Acquisition of High-Level Chromosomal Instability Is Associated with Integration of Human Papillomavirus Type 16 in Cervical Keratinocytes , 2004, Cancer Research.

[34]  C. Meijer,et al.  HPV‐mediated cervical carcinogenesis: concepts and clinical implications , 2006, The Journal of pathology.

[35]  S. Vinokurova,et al.  Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions , 2002, Oncogene.

[36]  S. J. Kim,et al.  Physical status and expression of HPV genes in cervical cancers. , 1997, Gynecologic oncology.

[37]  M. Sherman,et al.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. , 2003, The American journal of pathology.

[38]  M. Mravunac,et al.  Transition of high‐grade cervical intraepithelial neoplasia to micro‐invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities , 2004, The Journal of pathology.

[39]  M. Evans,et al.  Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses. , 1997, Cancer research.

[40]  C. Herrington,et al.  Interphase cytogenetic evidence for distinct genetic pathways in the development of squamous neoplasia of the uterine cervix. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[41]  J. Barrett,et al.  Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. , 2003, Carcinogenesis.

[42]  S. Syrjänen,et al.  Integrated Human Papillomavirus Type 16 Is Frequently Found in Cervical Cancer Precursors as Demonstrated by a Novel Quantitative Real-Time PCR Technique , 2002, Journal of Clinical Microbiology.

[43]  S. Månér,et al.  Genetic alterations in cervical carcinomas: Frequent low‐level amplifications of oncogenes are associated with human papillomavirus infection , 2002, International journal of cancer.